Do angiotensin II type 1 receptor blockers have molecular effects?-Reference-Cited by-同舟云学术

Do angiotensin II type 1 receptor blockers have molecular effects?

Published:2009-11-27 Issue:2 Volume:33 Page:105-106
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Miura Shin-ichiro,Saku Keijiro

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2009202.pdf

Reference26 articles.

1. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T . International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415–472.

2. Miura S, Fujino M, Saku K . Angiotensin II receptor blocker as an inverse agonist: a current perspective. Curr Hypertens Rev 2005; 1: 115–121.

3. Tsutamoto T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M . Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patinets with hypertension. Hypertens Res (e-pub ahead of print 20 November 2009; doi:10.1038/hr.2009.192).

4. Miura S, Fujino M, Hanzawa H, Kiya Y, Imaizumi S, Matsuo Y, Tomita S, Uehara Y, Karnik SS, Yanagisawa H, Koike H, Komuro I, Saku K . Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J Biol Chem 2006; 281: 19288–19295.

5. Le MT, Vanderheyden PM, Szaszák M, Hunyady L, Kersemans V, Vauquelin G . Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors. Biochem Pharmacol 2003; 65: 1329–1338.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Utility of Amlodipine/Valsartan Fixed-Dose Combination in the Management of Hypertension in Chinese Patients;Cardiovascular Innovations and Applications;2017-02-01

2. Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases;Pathophysiology and Pharmacotherapy of Cardiovascular Disease;2015

3. Comparison of the Efficacy and Safety of Irbesartan and Olmesartan in Patients With Hypertension (EARTH Study);Clinical and Experimental Hypertension;2012-05-08

4. Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-Pill Fixed-Dose Combination of Valsartan and Amlodipine;Journal of International Medical Research;2012-02

5. Nutritional Genomics of Vitamin D on Cardiovascular Disease;Nutritional Genomics;2011-12-05